New drug combo trial offers hope for Hard-to-Treat gut cancers
NCT ID NCT07165886
Summary
This study is testing whether combining two existing drugs works better than current options for advanced neuroendocrine tumors of the gut and pancreas. It's for patients whose cancer has spread and who have not yet received any systemic cancer treatment. The main goals are to see if the combination is safe, find the right dose, and measure how well it controls the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese PLA General Hospital
RECRUITINGBeijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.